Ad is loading...
KNSA
Price
$21.50
Change
+$0.52 (+2.48%)
Updated
Dec 6, 04:59 PM (EDT)
80 days until earnings call
RCKT
Price
$13.88
Change
+$0.56 (+4.20%)
Updated
Dec 6, 04:59 PM (EDT)
88 days until earnings call
Ad is loading...

KNSA vs RCKT

Header iconKNSA vs RCKT Comparison
Open Charts KNSA vs RCKTBanner chart's image
Kiniksa Pharmaceuticals International
Price$21.50
Change+$0.52 (+2.48%)
Volume$3.85K
CapitalizationN/A
Rocket Pharmaceuticals
Price$13.88
Change+$0.56 (+4.20%)
Volume$9.25K
CapitalizationN/A
KNSA vs RCKT Comparison Chart
Loading...
KNSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KNSA vs. RCKT commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNSA is a Hold and RCKT is a StrongBuy.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (KNSA: $21.51 vs. RCKT: $13.89)
Brand notoriety: KNSA and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNSA: 103% vs. RCKT: 78%
Market capitalization -- KNSA: $1.51B vs. RCKT: $1.21B
KNSA [@Biotechnology] is valued at $1.51B. RCKT’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNSA’s FA Score shows that 1 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • KNSA’s FA Score: 1 green, 4 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, KNSA is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNSA’s TA Score shows that 6 TA indicator(s) are bullish while RCKT’s TA Score has 6 bullish TA indicator(s).

  • KNSA’s TA Score: 6 bullish, 2 bearish.
  • RCKT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, both KNSA and RCKT are a good buy in the short-term.

Price Growth

KNSA (@Biotechnology) experienced а -2.58% price change this week, while RCKT (@Biotechnology) price change was -3.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

KNSA is expected to report earnings on Feb 26, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($1.52B) has a higher market cap than RCKT($1.21B). KNSA YTD gains are higher at: 22.634 vs. RCKT (-53.654). KNSA has higher annual earnings (EBITDA): -24.4M vs. RCKT (-247.25M). RCKT has more cash in the bank: 236M vs. KNSA (224M). KNSA has less debt than RCKT: KNSA (10.6M) vs RCKT (25.6M). KNSA has higher revenues than RCKT: KNSA (384M) vs RCKT (0).
KNSARCKTKNSA / RCKT
Capitalization1.52B1.21B125%
EBITDA-24.4M-247.25M10%
Gain YTD22.634-53.654-42%
P/E Ratio164.54N/A-
Revenue384M0-
Total Cash224M236M95%
Total Debt10.6M25.6M41%
FUNDAMENTALS RATINGS
KNSA vs RCKT: Fundamental Ratings
KNSA
RCKT
OUTLOOK RATING
1..100
596
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
42100
SMR RATING
1..100
8997
PRICE GROWTH RATING
1..100
5889
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for KNSA (93) in the Pharmaceuticals Major industry. This means that RCKT’s stock grew somewhat faster than KNSA’s over the last 12 months.

KNSA's Profit vs Risk Rating (42) in the Pharmaceuticals Major industry is somewhat better than the same rating for RCKT (100) in the Biotechnology industry. This means that KNSA’s stock grew somewhat faster than RCKT’s over the last 12 months.

KNSA's SMR Rating (89) in the Pharmaceuticals Major industry is in the same range as RCKT (97) in the Biotechnology industry. This means that KNSA’s stock grew similarly to RCKT’s over the last 12 months.

KNSA's Price Growth Rating (58) in the Pharmaceuticals Major industry is in the same range as RCKT (89) in the Biotechnology industry. This means that KNSA’s stock grew similarly to RCKT’s over the last 12 months.

KNSA's P/E Growth Rating (1) in the Pharmaceuticals Major industry is significantly better than the same rating for RCKT (100) in the Biotechnology industry. This means that KNSA’s stock grew significantly faster than RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KNSARCKT
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 18 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
KNSA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NGDCX29.660.20
+0.68%
Neuberger Berman Large Cap Growth C
CGCIX14.230.01
+0.07%
Calamos Global Opportunities I
DILRX16.89N/A
N/A
DFA International Large Cap Growth
AUERX17.35-0.20
-1.14%
Auer Growth
FZANX45.74-1.99
-4.17%
Fidelity Advisor New Insights Z

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with ABVC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then ABVC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+2.53%
ABVC - KNSA
40%
Loosely correlated
-5.66%
NTLA - KNSA
38%
Loosely correlated
+7.84%
FATE - KNSA
38%
Loosely correlated
+11.34%
AMRN - KNSA
36%
Loosely correlated
-1.77%
BEAM - KNSA
35%
Loosely correlated
+5.49%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+4.28%
DNLI - RCKT
53%
Loosely correlated
+6.73%
NTLA - RCKT
53%
Loosely correlated
+7.84%
AXON - RCKT
52%
Loosely correlated
-0.30%
FATE - RCKT
52%
Loosely correlated
+11.34%
PRME - RCKT
51%
Loosely correlated
+10.10%
More